Clinton Health Access Initiative will use award to expand access to SCD diagnostic tests and treatment in low- and ...
Wilson celebrates the first U.S. patient to complete gene therapy for sickle cell, but says advocacy must continue.
It may be possible to collect nearly three times as many stem cells for sickle cell gene therapy with motixafortide than standard plerixafor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback